302 related articles for article (PubMed ID: 33376322)
21. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
[TBL] [Abstract][Full Text] [Related]
22. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
23. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
Moodley T; Singh M
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046364
[TBL] [Abstract][Full Text] [Related]
24. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
25. Enhancing the cytotoxic efficacy of combined effect of doxorubicin and Cyclosporin encapsulated photoluminescent graphene dotted mesoporous nanoparticles against lung cancer cell-specific drug targeting for the nursing care of cancer patients.
Chen F; Zhang H; Jiang L; Wei W; Liu C; Cang S
J Photochem Photobiol B; 2019 Sep; 198():111578. PubMed ID: 31408842
[TBL] [Abstract][Full Text] [Related]
26. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh M; Saebfar H; Gholami MH; Hushmandi K; Zabolian A; Bikarannejad P; Hashemi M; Daneshi S; Mirzaei S; Sharifi E; Kumar AP; Khan H; Heydari Sheikh Hossein H; Vosough M; Rabiee N; Kumar Thakur V; Makvandi P; Mishra YK; Tay FR; Wang Y; Zarrabi A; Orive G; Mostafavi E
Expert Opin Drug Deliv; 2022 Apr; 19(4):355-382. PubMed ID: 35152815
[TBL] [Abstract][Full Text] [Related]
27. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
[No Abstract] [Full Text] [Related]
28. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
29. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
30. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
[TBL] [Abstract][Full Text] [Related]
31. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
[TBL] [Abstract][Full Text] [Related]
32. DPP-Cu
Chen W; Ma M; Lai Q; Zhang Y; Liu Z
Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
[TBL] [Abstract][Full Text] [Related]
33. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
Shen J; He Q; Gao Y; Shi J; Li Y
Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
[TBL] [Abstract][Full Text] [Related]
35. Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy.
Liu Y; Dai R; Wei Q; Li W; Zhu G; Chi H; Guo Z; Wang L; Cui C; Xu J; Ma K
ACS Appl Mater Interfaces; 2019 Nov; 11(47):44582-44592. PubMed ID: 31682097
[TBL] [Abstract][Full Text] [Related]
36. A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer.
Zhu L; Wang S
J Biomater Sci Polym Ed; 2023 Feb; 34(2):147-165. PubMed ID: 36136033
[TBL] [Abstract][Full Text] [Related]
37. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
38. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
39. Regulating intracellular ROS signal by a dual pH/reducing-responsive nanogels system promotes tumor cell apoptosis.
Dong K; Lei Q; Guo R; Wu X; Zhang Y; Cui N; Shi JY; Lu T
Int J Nanomedicine; 2019; 14():5713-5728. PubMed ID: 31413571
[No Abstract] [Full Text] [Related]
40. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
